scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104022400 |
P356 | DOI | 10.1186/S12879-018-3133-6 |
P932 | PMC publication ID | 5956841 |
P698 | PubMed publication ID | 29769036 |
P50 | author | Patrick S. Sullivan | Q39915183 |
Eric William Hall | Q59768204 | ||
P2093 | author name string | Eli S Rosenberg | |
P2860 | cites work | Higher incidence of HCV in females compared to males who inject drugs: A systematic review and meta-analysis | Q38993437 |
The changing epidemiology of hepatitis C virus infection in the United States: National Health and Nutrition Examination Survey 2001 through 2010. | Q39304230 | ||
Reasons why patients infected with chronic hepatitis C virus choose to defer treatment: do they alter their decision with time? | Q40234175 | ||
Race and Gender Differences in the Use of Direct Acting Antiviral Agents for Hepatitis C Virus. | Q40774593 | ||
Hepatitis C in the United States | Q42992102 | ||
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence | Q43419544 | ||
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. | Q44979610 | ||
African Americans may differ in their reasons for declining hepatitis C therapy compared to non-African Americans | Q45867712 | ||
Natural History of Hepatitis C. | Q50934392 | ||
Racial differences in the evaluation and treatment of hepatitis C among veterans: a retrospective cohort study. | Q53036392 | ||
Healthy People 2010 criteria for data suppression | Q74459533 | ||
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections | Q28538968 | ||
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection | Q33650138 | ||
Estimation of State-Level Prevalence of Hepatitis C Virus Infection, US States and District of Columbia, 2010 | Q33696050 | ||
Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection | Q33853655 | ||
The natural history of hepatitis C virus infection: host, viral, and environmental factors | Q33974693 | ||
Toward a more accurate estimate of the prevalence of hepatitis C in the United States | Q34484872 | ||
Reasons for HCV non-treatment in underserved African Americans: implications for treatment with new therapeutics | Q35258724 | ||
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010 | Q36035889 | ||
Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan | Q36104175 | ||
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies | Q36346436 | ||
Racial/ethnic differences in spontaneous HCV clearance in HIV infected and uninfected women | Q36874791 | ||
Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States | Q36988702 | ||
Racial differences in hepatitis C treatment eligibility | Q37077462 | ||
Chronic hepatitis C virus (HCV) disease burden and cost in the United States | Q37148328 | ||
Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. | Q37525298 | ||
The dynamics of diabetes among birth cohorts in the U.S. | Q37660898 | ||
P433 | issue | 1 | |
P921 | main subject | United States of America | Q30 |
Hepatitis C virus | Q708693 | ||
chronic hepatitis C | Q55779873 | ||
P304 | page(s) | 224 | |
P577 | publication date | 2018-05-16 | |
P1433 | published in | BMC Infectious Diseases | Q15759919 |
P1476 | title | Estimates of state-level chronic hepatitis C virus infection, stratified by race and sex, United States, 2010. | |
P478 | volume | 18 |
Q90095540 | Hepatitis C Virus Prevalence in 50 U.S. States and D.C. by Sex, Birth Cohort, and Race: 2013-2016 |
Q89623977 | Liver cancer: A leading cause of cancer death in the United States and the role of the 1945-1965 birth cohort by ethnicity |
Q92347599 | Seroprevalence of markers of hepatitis C virus exposure and associated factors in adults aged 18-39 years in the Arctic Russian city of Arkhangelsk: a cross-sectional study |
Search more.